Results for "consumer data right"
441-450 of 537 results for 'consumer data right'
Capacity Investment Scheme now open for business: will it solve the capacity conundrum?
The first standalone Capacity Investment Scheme (CIS) tender round is now well underway, with Stage A 'Project bids' submitted in February. While we wait to see the final form clean dispatchable CISA and to hear the results of the tender round, we consider the current state of play. ...
No more 'two-stepping' around manner of manufacture?
Australia’s approach to patenting computer‑implemented inventions has just shifted decisively. In Aristocrat Technologies Australia Pty Ltd v Commissioner of Patents [2025] FCAFC 131, the Full F ...
Dollars and sense: the evolution of executive remuneration practices
The need for robust executive remuneration frameworks is becoming increasingly important as companies tackle the challenges arising out of the COVID-19 pandemic, a heightened regulatory environment and the need to strike the right balance with executives to drive and reward conduct and performance t ...
New ASIC guidance on how superannuation and managed funds can avoid 'greenwashing'
Greenwashing in the promotion of managed investment and superannuation funds is one of ASIC's current corporate governance priorities as it continues to 'monitor the market … looking for misleading claims about ESG and sustainability'. ...
It's nearly here: how businesses can prepare for mandatory climate-related financial reporting
A mandatory climate disclosure will commence for the first cohort of reporting entities from 2024-2025, and firms up details on the overall architecture of a reporting regime which is now expected to cover around 20,000 Australian organisations. ...
Leveraging IP in a future minerals world
Future minerals, such as lithium, copper, nickel and rare earths, are critical to many clean energy technologies and the transition to renewable energy solutions. ...
Regulatory scrutiny of private capital increases
Private capital is becoming a growing focus of regulators, both in Australia and internationally, given the ever-increasing flow of capital to the sector in recent years. ...
ASIC ramps up greenwashing-related regulatory interventions, targeting managed funds and ASX listed entities
ASIC's latest report, ASIC's recent greenwashing interventions (the Report), outlines its recent surveillance activities and regulatory interventions to tackle misleading marketing and greenwashing. ...
World first: Australia says ‘yes’ to AI inventors
The decision in Thaler v Commissioner of Patents [2021] FCA 879 is the first judicial determination in the world in favour of AI systems being named as inventors of a patent. The availability of patent protection for AI-generated inventions is a vexed and controversial issue. ...
Interlocutory injunction refused based on 'doubtful' patent term extension
In the fight against patent infringement, challenging the validity of patent term extensions (PTEs) is increasingly becoming the weapon of choice for generic pharmaceutical companies. Since around the mid-2000s, patentees in pharmaceutical patent cases have typically been successful in bids for interlocutory injunctions, aiming to prevent the launch of generic products in Australia. The recent Biogen decision by the Federal Court is the latest in a trend of refusing interlocutory injunctions, and a clear indication the tide is turning. ...